Understanding Long Noncoding RNA and Chromatin Interactions: What We Know So Far

被引:74
|
作者
Mishra, Kankadeb [1 ,2 ]
Kanduri, Chandrasekhar [1 ]
机构
[1] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, S-40530 Gothenburg, Sweden
[2] Mem Sloan Kettering Canc Ctr, Dept Cell Biol, Rockefeller Res Lab, 430 East 67th St,RRL 445, New York, NY 10065 USA
基金
瑞典研究理事会;
关键词
lncrna; chromatin; chromatin RNA; long noncoding RNA; gene regulation; RNA-chromatin interactions; REPEAT-CONTAINING RNA; R-LOOP FORMATION; ANTISENSE TRANSCRIPTION; WIDE IDENTIFICATION; ACTIVE CHROMATIN; BINDING PROTEIN; ENHANCER RNAS; CIRCULAR RNAS; X-CHROMOSOME; MAPS REVEAL;
D O I
10.3390/ncrna5040054
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With the evolution of technologies that deal with global detection of RNAs to probing of lncRNA-chromatin interactions and lncRNA-chromatin structure regulation, we have been updated with a comprehensive repertoire of chromatin interacting lncRNAs, their genome-wide chromatin binding regions and mode of action. Evidence from these new technologies emphasize that chromatin targeting of lncRNAs is a prominent mechanism and that these chromatin targeted lncRNAs exert their functionality by fine tuning chromatin architecture resulting in an altered transcriptional readout. Currently, there are no unifying principles that define chromatin association of lncRNAs, however, evidence from a few chromatin-associated lncRNAs show presence of a short common sequence for chromatin targeting. In this article, we review how technological advancements contributed in characterizing chromatin associated lncRNAs, and discuss the potential mechanisms by which chromatin associated lncRNAs execute their functions.
引用
收藏
页数:28
相关论文
共 50 条
  • [31] TAVI in nonagenarians, what do we know so far?
    Diez-Villanueva, Pablo
    Rivero, Fernando
    REC-INTERVENTIONAL CARDIOLOGY, 2021, 3 (04): : 245 - 246
  • [32] China coronavirus: what do we know so far?
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 368 : m308
  • [33] Refractory hypertension: what do we know so far?
    Muxfeldt, Elizabeth Silaid
    Chedier, Bernardo
    JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (03) : 181 - 183
  • [34] Trends in HeartMate 3: What we know so far
    Lanfear, Allison T.
    Hamandi, Mohanad
    Fan, Joy
    DiMaio, J. Michael
    George, Timothy J.
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (01) : 180 - 187
  • [35] Diet in the Treatment of Epilepsy: What We Know So Far
    Verrotti, Alberto
    Iapadre, Giulia
    Di Francesco, Ludovica
    Zagaroli, Luca
    Farello, Giovanni
    NUTRIENTS, 2020, 12 (09) : 1 - 19
  • [36] Mitochondrial cytopathy in adults: What we know so far
    Cohen, BH
    Gold, DR
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2001, 68 (07) : 625 - +
  • [37] Visual snow syndrome: what we know so far
    Puledda, Francesca
    Schankin, Christoph
    Digre, Kathleen
    Goadsby, Peter J.
    CURRENT OPINION IN NEUROLOGY, 2018, 31 (01) : 52 - 58
  • [38] Fire effects on anurans: What we know so far?
    dos Anjos, Amanda Gomes
    Sole, Mirco
    Benchimol, Maira
    FOREST ECOLOGY AND MANAGEMENT, 2021, 495
  • [39] Monkeypox transmission-what we know so far
    Venkatesan, Priya
    LANCET RESPIRATORY MEDICINE, 2022, 10 (11): : E101 - E101
  • [40] Mpox infection in neonates: what we know so far?
    Kumar, Jogender
    Meena, Jitendra
    PAEDIATRICS AND INTERNATIONAL CHILD HEALTH, 2022, 42 (3-4) : 173 - 174